Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens (Q34460068)

2 August 2017

title

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens (English)

1 reference

2 August 2017

1 reference

J Dantal

1

1 reference

2 August 2017

M Hourmant

2

1 reference

2 August 2017

D Cantarovich

3

1 reference

2 August 2017

M Giral

4

1 reference

2 August 2017

G Blancho

5

1 reference

2 August 2017

B Dreno

6

1 reference

2 August 2017

J P Soulillou

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

2 August 2017

1 reference

2 August 2017

volume

351

1 reference

2 August 2017

issue

9103

1 reference

2 August 2017

page(s)

623-628

1 reference

A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Anti-CD4 MoAb therapy in kidney transplantation--a pilot study in early prophylaxis of rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Long-term efficacy and safety of cyclosporine in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Sirolimus: a new agent for clinical renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Transplantation. Beware: shifting paradigms ahead.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Anti-tumor activity of mycophenolate mofetil against human and mouse tumors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Risk of neoplasia in renal transplant patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Premalignant and malignant skin lesions in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Kidney transplant recipients who die with functioning grafts: serum creatinine level and cause of death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Viral infection and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

World distribution of factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2908496-1

7 January 2021

10.1016/S0140-6736(97)08496-1

Identifiers

DOI

1 reference

2 August 2017

1 reference